Wall Street thinks the FDA's latest crackdown on e-cigs might actually be good news for Juul

Singapore News News

Wall Street thinks the FDA's latest crackdown on e-cigs might actually be good news for Juul
Singapore Latest News,Singapore Headlines
  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 51%

Analysts think the FDA's moves could positively impact Juul, which currently represents eight out of every 10 e-cigarettes on the market.

by Altria, the maker of Marlboro cigarettes — currently represents eight out of every 10 e-cigarettes on the market.Instead of negatively impacting Juul, several analysts think the restrictions could give them a small boost. That's because the crackdown could make Juul competitors follow its lead in pulling its sweet varieties from retail stores.its flavored e-cigarette varieties — fruit, creme, and mango — from retail stores.

"We believe this is a near-term positive for Altria, with competitors forced to remove flavored products from outlets that Juul already voluntarily removed its products," analysts with investment bank Stifel wrote in a note circulated on Wednesday.In another Wednesday note, they wrote that companies like British American Tobacco and Imperial — who make the e-cigarettes Vype, Vuse, and Blu, respectively — still have fruity flavored products on the market.

"If anything, one could argue that these actions help level the playing field for Juul and allow for sales in comparable distribution channels," the Cowen analysts concluded.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

BusinessInsider /  🏆 729. in US

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Juul is pitching its e-cigarette as an anti-smoking tool to employers and insurersJuul is pitching its e-cigarette as an anti-smoking tool to employers and insurersJuul created a new enterprise markets team to strike deals with health plans, providers, self-insured employers, as well as public sector.
Read more »

FDA tightens restrictions on e-cigarette sales and fruity flavors to stem teen vapingFDA tightens restrictions on e-cigarette sales and fruity flavors to stem teen vapingFDA tightens restrictions on e-cigarette sales and fruity flavors to stem teen vaping.
Read more »

FDA rolls out vaping policy to make it harder for minors to buy flavored productsFDA rolls out vaping policy to make it harder for minors to buy flavored productsThe Food and Drug Administration issued a much-anticipated policy on Wednesday designed to restrict how and where flavored e-cigarettes are sold — an effort to combat what the agency’s commissioner has called “an epidemic” of underage vaping.
Read more »

FDA outlines e-cigarette rules, tightens restrictions on fruity flavors to try to curb teen vapingFDA outlines e-cigarette rules, tightens restrictions on fruity flavors to try to curb teen vapingOutgoing FDA chief Scott Gottlieb released the agency's much-anticipated draft rules restricting e-cigarette sales, tightening sales and eventually remove from the market many of the fruity flavors he's blamed on fueling an 'epidemic' of teen use.
Read more »

National Cancer Institute Director Ned Sharpless named acting FDA commissionerNational Cancer Institute Director Ned Sharpless named acting FDA commissionerNational Cancer Institute Director Ned Sharpless will serve as acting FDA Commissioner when Scott Gottlieb steps down from the agency next month, Health and Human Services Secretary Alex Azar said Tuesday.
Read more »

Nation’s cancer chief appointed acting FDA commissionerNation’s cancer chief appointed acting FDA commissionerNorman 'Ned' Sharpless has been named acting head of the Food and Drug Administration.
Read more »

Norman Sharpless, National Cancer Institute chief, appointed acting FDA commissionerNorman Sharpless, National Cancer Institute chief, appointed acting FDA commissionerNational Cancer Institute Director Norman “Ned” Sharpless will become acting commissioner of the Food and Drug Administration, succeeding Scott Gottlieb who is leaving next month, Health and Human Services Secretary Alex Azar told Congress Tuesday.
Read more »

NIH cancer chief to serve as acting FDA commissionerNIH cancer chief to serve as acting FDA commissionerDr. Ned Sharpless, who manages billions in funding for cancer research, has supported efforts to more tightly regulate tobacco and limit underage vaping.
Read more »

FDA approves new generic valsartan to make up for drug shortageFDA approves new generic valsartan to make up for drug shortageThe US Food and Drug Administration approved a new generic of valsartan to help relieve the recent shortage of the medicine, which is used to treat high blood pressure
Read more »



Render Time: 2025-04-07 11:55:26